Registro:

Referencias:

• Bastón, J.I., Barañao, R.I., Ricci, A.G., Bilotas, M.A., Olivares, C.N., Singla, J.J., Gonzalez, A.M., Rabinovich, G.A., Targeti ng galectin-1-induced angiogenesis mitigates the severity of endometriosis (2014) J Pathol
• Bax, M., García-Vallejo, J.J., Jang-Lee, J., North, S.J., Gilmartin, T.J., Hernández, G., Crocker, P.R., Haslam, S.M., Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins (2007) J Immunol, 179, pp. 8216-8224
• Benedito, R., Roca, C., Sorensen, I., Adams, S., Gossler, A., Fruttiger, M., Adams, R.H., The notch ligands dll4 and jagged1 have opposing effects on angiogenesis (2009) Cell, 137, pp. 1124-1135
• Bergers, G., Hanahan, D., Modes of resistance to anti-Angiogenic therapy (2008) Nat Rev Cancer, 8, pp. 592-603
• Boscher, C., Dennis, J.W., Nabi, I.R., Glycosylation, galectins and cellular signaling (2011) Curr Opin Cell Biol, (23), pp. 383-392
• Cardenas-Delgado, V.M., Nugnes, L.G., Colombo, L.L., Troncoso, M.F., Fernandez, M.M., Malchiodi, E.L., Malchiodi, E.L., Compagno, D., Modulation of endothelial cell migration a nd angiogenesis: A novel function for the tandem-repeat lectin galectin-8 (2011) FASEB J, 25, pp. 242-254
• Carlini, M.J., Roitman, P., Nuñez, M., Pallotta, M.G., Boggio, G., Smith, D., Salatino, M., Puricelli, L.I., Clinical relevance of galectin-1 expression in non-small cell lung cancer patients (2014) Lung Cancer, (84), pp. 73-78
• Carmeliet, P., Jain, R.K., Molecular mechanisms and clinical applications of angiogenesis (2011) Nature, 473, pp. 298-307
• Chen, C., Duckworth, C.A., Fu, B., Pritchard, D.M., Rhodes, J.M., Yu, L.G., Circulating galectins-2,-4 and-8 in cancer patients make important contributions to the increased circulation of sev eral cytokines and chemokines that promote angiogenesis and metastasis (2014) Br J Cancer, (110), pp. 741-752
• Chung, A.S., Wu, X., Zhuang, G., Ngu, H., Kasman, I., Zhang, J., Vernes, J.M., Peale, F.V., An il-17-mediated paracrine network promotes tumor resistance to anti-Angiogenic therapy (2013) Nat Med, (19), pp. 1114-1123
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Méndez-Huergo, S.P., Mascanfroni, D.I., Dergan-Dylon, L.S., Toscano, M.A., Ouyang, J., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-vegf refractory tumors (2014) Cell, 156, pp. 744-758
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Ouyang, J., Domaica, C.I., Disrupting galectin-1 interactions with n-glycans suppresses hypoxia-dri ven angiogenesis and tumorigenesis in kaposi's sarcoma (2012) J Exp Med, 209, pp. 1985-2000
• Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Méndez-Huergo, S.P., Stupirski, J.C., Toscano, M.A., Targeting galectin-1 overcomes breast cancer-Associated immunosuppression and prevents metastatic disease (2013) Cancer Res, 73, pp. 1107-1117
• De Palma, M., Venneri, M.A., Galli, R., Sergi Sergi, L., Politi, L.S., Sampaolesi, M., Naldini, L., Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal pop ulation of pericyte progenitors (2005) Cancer Cell, 8, pp. 211-226
• D'Haene, N., Sauvage, S., Maris, C., Adanja, I., Le Mercier, M., Decaestecker, C., Baum, L., Salmon, I., Vegfr1 and vegfr2 involvement in extra cellular galectin-1-And galectin-3-induced angiogenesis (2013) PLoS ONE, 8, p. e67029
• Dings, R.P., Loren, M., Heun, H., McNiel, E., Griffioen, A.W., Mayo, K.H., Griffin, R.J., Scheduling of radiation with angiogenesi s inhibitors anginex and avastin improves therapeutic outcome via vessel normalization (2007) Clin Cancer Res, 13, pp. 3395-3402
• Ebos, J.M., Lee, C.R., Cruz-Munoz, W., Bjarnason, G.A., Christensen, J.G., Kerbel, R.S., Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis (2009) Cancer Cell, 15, pp. 232-239
• Etulain, J., Negrotto, S., Tribulatti, M.V., Croci, D.O., Carabelli, J., Campetella, O., Rabinovich, G.A., Schattner, M., Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors (2014) PLoS ONE, 4, p. e96402
• Ferrara, N., Hillan, K.J., Gerber, H.P., Novotny, W., Discovery and development of bevacizumab, an anti-vegf antibody for treating cancer (2004) Nat Rev Drug Discov, 5, pp. 391-400
• Folkman, J., Tumor angiogenesis: Therapeutic implications (1971) N Engl J Med, 285, pp. 1182-1186
• Freitag, N., Tirado-González, I., Barrientos, G., Herse, F., Thijssen, V.L., Weedon-Fekjaer, S.M., Schulz, H., Nevers, T., Interfering with gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia (2013) Proc Natl Acad Sci USA, 110, pp. 11451-11456
• Garcia-Vallejo, J.J., Van Dijk, W., Van Het Hof, B., Van Die, I., Engelse, M.A., Van Hinsbergh, V.W., Gringhuis, S.I., Activation of human endothelial cells by tumor necrosis factor-Alpha results in profound changes in the expression of glycosylation-related genes (2006) J Cell Physiol, 206, pp. 203-210
• Garner, O.B., Baum, L.G., Galect in-glycan lattices regulate cell-surface glycoprotein organization and signalling (2008) Biochem Soc Trans, 6, pp. 1472-1477
• Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D.J., Witte, L., Placental growth factor reconstitutes hematopoiesis by recruiting vegfr1(+) stem cells from bone-marrow microenvironment (2002) Nat Med, 8, pp. 841-849
• Heusschen, R., Schulkens, I.A., Van Beijnum, J., Griffioen, A.W., Thijssen, V.L., Endothelial lgals9 splice variant expression in endothelial cell biology and angiogenesis (2014) Biochim Biophys Acta, pp. 284-292. , 18422
• Hodi, F.S., Lawrence, D., Lezcano, C., Wu, X., Zhou, J., Sasada, T., Zeng, W., Ibrahim, N., Bevacizumab plus ipilimumab in patients with metastatic melanoma (2014) Cancer Immunol Res, (2), pp. 632-642
• Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Galectin-1, a novel ligand of neuropilin-1, activates vegfr-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 26, pp. 3746-3753
• Kerbel, R.S., Tumor angiogenesis (2008) N Engl J Med, 358, pp. 2039-2049
• Ki, M.K., Jeoung, M.H., Choi, J.R., Rho, S.S., Kwon, Y.G., Shim, H., Chung, J., Lee, S., Human antibodies targeting the c-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro (2013) Oncogene, (48), pp. 5449-5457
• Kitazume, S., Imamaki, R., Ogawa, K., Komi, Y., Futakawa, S., Kojima, S., Hashimoto, Y., Taniguchi, N., 2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling (2010) J Biol Chem, 285, pp. 6515-6521
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., Al Nakouzi, N., Mazza, O., A unique galectin signature in huma n prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res, (73), pp. 86-96
• Langbein, S., Brade, J., Badawi, J.K., Hatzinger, M., Kaltner, H., Lensch, M., Specht, K., Alken, P., Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance (2007) Histopathology, 51, pp. 681-690
• Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Zhao, S., O'Byrne, K.J., Galectin-1: A link between tumor hypoxia and tumor immune privilege (2005) J Clin Oncol, 23, pp. 8932-8941
• Loges, S., Mazzone, M., Hohensinner, P., Carmeliet, P., Silencing or fueling metastasis with vegf inhibitors: Antiangiogenesis revisited (2009) Cancer Cell, 15, pp. 167-170
• Machado, C.M., Andrad, E.L.N., Teixeira, V.R., Costa, F.F., Melo, C.M., Dos Santos, S.N., Nonogaki, S., Camargo, A.A., Galectin-3 disruption impaired tumoral angiogenesis by reducing vegf secretion from tgf?1-induced macrophages (2014) Cancer Med, 3, pp. 201-214
• Mariñ, O.K., Bones, J., Kattla, J.J., Rudd, P.M., A systematic approach to protein glycosylation analysis: A path through the maze (2010) Nat Chem Biol, 6, pp. 713-723
• Markowska, A.I., Jefferies, K.C., Panjwani, N., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells (2011) J Biol Chem, 286, pp. 29913-29921
• Ma rkowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of vegf-And bfgf-mediated angiogenic response (2010) J Exp Med, 207, pp. 1981-1993
• Martínez-Bosch, N., Fernández-Barrena, M.G., Moreno, M., Ortiz-Zapater, E., Munné-Collado, J., Iglesias, M., André, S., Poirier, F., Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and hedgehog signaling activation (2014) Cancer Res, (74), pp. 3512-3524
• Mathieu, V., De Lassalle, E.M., Toelen, J., Mohr, T., Bellahcene, A., Van Goietsenoven, G., Verschuere, T., De Vleeschouwer, S., Galectin-1 in melanoma biol ogy and related neo-Angiogenesis processes (2012) J Invest Dermatol, 132, pp. 2245-2254
• Murdoch, C., Muthana, M., Coffelt, S.B., Lewis, C.E., The role of myeloid cells in the promotion of tumour angiogenesis (2008) Nat Rev Cancer, 8, pp. 618-631
• Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., Raz, A., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am J Pathol, 156, pp. 899-909
• Nangia-Makker, P., Wang, Y., Raz, T., Tait, L., Balan, V., Hogan, V., Raz, A., Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer (2010) Int J Cancer, 127, pp. 2530-2541
• Ohtsubo, K., Marth, J.D., Glycosylation in cellular mechanisms of health and disease (2006) Cell, 126, pp. 855-856
• Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Casanovas, O., Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis (2009) Cancer Cell, 15, pp. 220-231
• Piccolo, E., Tinari, N., Semera ro, D., Traini, S., Fichera, I., Cumashi, A., La Sorda, R., Lattanzio, R., Lgals3bp, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in huma n breast cancer cells and promotes angiogenesis (2013) J Mol Med (Berl), 91, pp. 83-94
• Potente, M., Gerhardt, H., Carmeliet, P., Basic and therapeutic aspects of angiogenesis (2011) Cell, 146, pp. 873-887
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Shojaei, F., Lee, J.H., Simmons, B.H., Wong, A., Esparza, C.O., Plumle, E.P.A., Feng, J., Christensen, J.G., Hgf/c-met acts as an alternative angiogenic pathway in sunitinib-resistant tumors (2010) Cancer Res, (70), pp. 10090-10100
• Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.H., Yao, J., Blanchard, D., Van Bruggen, N., Bv8 regulates myeloid-cell-dependent tumour angiogenesis (2007) Nature, 450, pp. 825-831
• Stanley, P., Guidos, C.J., Regulation of notch signaling during t-And b-cell development by o-fucose glycans (2009) Immunol Rev, 230, pp. 201-215
• Starossom, S.C., Mascanfroni, I.D., Imitola, J., Cao, L., Raddassi, K., Hernandez, S.F., Bassil, R., Delacour, D., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration (2012) Immunity, 37, pp. 249-263
• St. Croix, B.S., Rago, C., Velculescu, V., Traverso, G., Romans, K.E., Montgomery, E., Lal, A., Vogelstein, B., Genes expressed in human tumor endothelium (2000) Science, 289, pp. 1197-1202
• Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Hackeng, T.M., Poirier, F., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70, pp. 6216-6224
• Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Bakkers, J., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc Natl Acad Sci USA, 103, pp. 15975-15980
• Thijssen, V.L., Rabinovich, G.A., Griffioen, A.W., Vascular galectins: Regulators of tumor progression and targets for cancer therapy (2013) Cytokine Growth Factor Rev, 10, pp. 1359-6101
• Toscano, M.A., Bianco, G.A., Larregui J M, I., Croci, D.O., Correale, J., Hernandez, J.D., Zwirner, N.W., Baum, L.G., Differential glycosylation of th1, th2 and th-17 effector cells selectively regulates susceptibility to cell d eath (2007) Nat Immunol, 8, pp. 825-834
• Van Beijnum, J.R., Dings, R.P., Van Der Linden, E., Zwaans, B.M., Ramaekers, F.C., Mayo, K.H., Griffioen, A.W., Gene expression of tumor angiogenesis dissected: Specific targe ting of colon cancer angiogenic vasculature (2006) Blood, 108, pp. 2339-2348
• Van Kooyk, Y., Rabinovich, G.A., Protein-glycan interactions in the control of innate and adaptive immune responses (2008) Nat Immunol, 9, pp. 593-601
• Van Wijk, X.M., Thijssen, V.L., Lawrence, R., Van Den Broek, S.A., Dona, M., Naidu, N., Oosterhof, A., Khaled, Y., Interfering with udp-glcnac metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis (2013) ACS Chem Biol, (8), pp. 2331-2338
• Varki, A., Kannagi, R., Toole, B.P., Glycosylation changes in cancer (2009) Essentials of Glycobiology, , In: Varki A, Cummings RD, Esko JD, Fr eeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. Chapter 44
• Verschuere, T., Toelen, J., Maes, W., Poirier, F., Boon, L., Tousse yn, T., Mathivet, T., Kiss, R., Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity Int J Cancer, 2014 (134), pp. 873-884
• Willhauck-Fleckenstein, M., Moehler, T.M., Merling, A., Pusunc, S., Goldschmidt, H., Schwartz-Albiez, R., Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling (2010) Angiogenesis, 13, pp. 25-42
• Wu, M.H., Ying, N.W., Hong, T.M., Chiang, W.F., Lin, Y.T., Chen, Y.L., Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex (2014) Angiogenesis, , Advance Access published April 10 2014
• Xu, D., Fuster, M.M., Lawrence, R., Esko, J.D., Heparan sulfate regulates vegf165-And vegf121-mediated vascular hyperpermeability (2011) J Biol Chem, 286, pp. 737-745
• Zhao, X.Y., Zhao, K.W., Jiang, Y., Zhao, M., Chen, G.Q., Synergistic induction of galectin-1 by ccaat/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute mye loid leukemic cells J Biol Chem, 2011 (286), pp. 36808-36819
• Zucchetti, M., Bonezzi, K., Frapolli, R., Sala, F., Borsotti, P., Zangarini, M., Cvitkovic, E., Giavazzi, R., Ph armacokinetics and antineoplastic activity of galectin-1-targeting otx008 in combination with sunitinib (2013) Cancer Chemother Pharmacol, 72, pp. 879-887

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------